Novel Treatment for Gout and Hyperuricemia
Intra-articular injections of modified hyaluronic acid significantly reduces inflammation-induced swelling in gout
Published: 4th October 2018

Patents
- Pharmaceutical composition claims granted in US Patent US 9,644,050 “Hyaluronic Acid Derivatives” and in Japanese Patent JP6363119B2. Method of treating hyperuricemia and gout claimed in US provisional patent application 62/640,910 titled “N-butyrylated Hyaluronic Acid for Hyperuricemia and Gouty Arthritis”
IP Status
- Patented
- Patent application submitted
Seeking
- Development partner
- Licensing
- Seeking investment